Morgan Stanley Haleon PLC Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Haleon PLC stock. As of the latest transaction made, Morgan Stanley holds 10,279,456 shares of HLN stock, worth $99 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,279,456
Previous 9,891,621
3.92%
Holding current value
$99 Million
Previous $94.6 Million
11.86%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding HLN
# of Institutions
686Shares Held
476MCall Options Held
166KPut Options Held
27.2K-
Dodge & Cox San Francisco, CA155MShares$1.5 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$303 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ23.1MShares$222 Million1.89% of portfolio
-
Wellington Management Group LLP Boston, MA18.7MShares$180 Million0.04% of portfolio
-
Ubs Group Ag14.4MShares$138 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.5B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...